--:--:--LOCAL ·--:--UTC
    US EQUITIESLAST CLOSE
    AAPL$344.63-1.23%
    MSFT$521.91-1.55%
    GOOGL$279.84-1.40%
    AMZN$240.35-1.41%
    NVDA$204.64-4.22%
    META$614.99-1.53%
    TSLA$399.81-0.87%
    NFLX$62.08+0.05%
    BRK.B$542.49+0.10%
    AVGO$326.08-5.48%
    DIS$110.94+0.03%
    SBUX$103.67-1.74%
    MCD$258.12+0.29%
    NKE$38.67+0.65%
    COST$1012.28+1.63%
    WMT$123.51+1.86%
    HD$329.20+0.07%
    KO$94.08+1.36%
    PG$161.57+0.61%
    ORCL$130.67-6.37%
    CRM$229.17-0.75%
    ADBE$250.23+0.85%
    AMD$504.80-10.88%
    INTC$65.76-28.58%
    QCOM$164.79-11.12%
    CSCO$104.51-3.76%
    IBM$257.81-0.18%
    UBER$65.25-0.75%
    ABNB$164.39-1.24%
    SHOP$157.49-5.63%
    PYPL$57.01+0.11%
    COIN$143.54-10.62%
    PLTR$184.11-6.27%
    HOOD$84.99-7.21%
    JPM$337.04-1.90%
    V$413.59+0.74%
    MA$638.01+0.36%
    BAC$50.01-2.21%
    GS$894.55-3.58%
    LLY$1417.54+3.19%
    UNH$406.97-0.96%
    JNJ$273.20-0.73%
    PFE$30.52+1.90%
    XOM$187.25+2.16%
    BA$171.55-0.64%
    BABA$98.04-1.51%
    TSM$406.13-5.95%
    US EQUITIESLAST CLOSE
    AAPL$344.63-1.23%
    MSFT$521.91-1.55%
    GOOGL$279.84-1.40%
    AMZN$240.35-1.41%
    NVDA$204.64-4.22%
    META$614.99-1.53%
    TSLA$399.81-0.87%
    NFLX$62.08+0.05%
    BRK.B$542.49+0.10%
    AVGO$326.08-5.48%
    DIS$110.94+0.03%
    SBUX$103.67-1.74%
    MCD$258.12+0.29%
    NKE$38.67+0.65%
    COST$1012.28+1.63%
    WMT$123.51+1.86%
    HD$329.20+0.07%
    KO$94.08+1.36%
    PG$161.57+0.61%
    ORCL$130.67-6.37%
    CRM$229.17-0.75%
    ADBE$250.23+0.85%
    AMD$504.80-10.88%
    INTC$65.76-28.58%
    QCOM$164.79-11.12%
    CSCO$104.51-3.76%
    IBM$257.81-0.18%
    UBER$65.25-0.75%
    ABNB$164.39-1.24%
    SHOP$157.49-5.63%
    PYPL$57.01+0.11%
    COIN$143.54-10.62%
    PLTR$184.11-6.27%
    HOOD$84.99-7.21%
    JPM$337.04-1.90%
    V$413.59+0.74%
    MA$638.01+0.36%
    BAC$50.01-2.21%
    GS$894.55-3.58%
    LLY$1417.54+3.19%
    UNH$406.97-0.96%
    JNJ$273.20-0.73%
    PFE$30.52+1.90%
    XOM$187.25+2.16%
    BA$171.55-0.64%
    BABA$98.04-1.51%
    TSM$406.13-5.95%
    Plug stock market data into your AI agent — one command: Get your free API key →
    LoginGet API Key
    Company data coverage · ASX

    RNV — RENERVE LIMITED

    Data coverage, completeness and provenance for RENERVE LIMITED in the Stock Market API — Health Care · Biotechnology.

    ASX AUS
    Core-field completeness
    82.4%
    Statement periods
    FY2023–FY2026
    Filings archived
    1 (1 md)
    Price collection time
    2026-11-01 07:15 UTC

    Stored price coverage

    Source date: 2026-10-28T04:43:37. Source: yfinance. Collection time is shown separately and does not establish a trade date.

    Recent stored price bars, without investment interpretation
    DateCloseCurrencySourceAdjustment basis
    2026-10-300.0900AUDyfinanceSplit- and dividend-adjusted close
    2026-10-290.0900AUDyfinanceSplit- and dividend-adjusted close
    2026-10-280.0900AUDyfinanceSplit- and dividend-adjusted close
    2026-10-270.0920AUDyfinanceSplit- and dividend-adjusted close
    2026-10-260.0930AUDyfinanceSplit- and dividend-adjusted close

    GET /api/v1/companies/RNV/prices · Price parameters and adjustment semantics

    Dataset availability · Handle missing data

    Profile

    ReNerve Limited, a medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures in New Zealand and the United States. It develops Nerve Cuff, a bioabsorbable protective wrap used to protect repaired nerves; and Nerve Graft, an off-the-shelf nerve grafts for the repair of damaged nerves under the NervAlign brand. The company also offers dermal tissue product, a deep dermal product used in the repair of reconstructive and cosmetic surgical cases; and amniotic tissue product ranges used to aid the healing of wounds under the Empliq brand. In addition, it provides Nerve Conduit Range, a nerve conduit designed to facilitate nerve growth over short gaps between nerve ends; bionic nerve, a novel combination polymer technology; and Nerve Guide Matrix for treating more severe nerve injuries, but eliminating the need for patients to undergo additional sural nerve harvesting under the NervAlign brand that are in development phase. The company was incorporated in 2016 and is headquartered in Northcote, Australia.

    Website: https://renerve.com.au · Profile fields populated: 60%

    Data completeness by statement

    Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/RNV/financials.

    Income statement10/10 fields (100.0%)
    Balance sheet13/14 fields (92.9%)
    Cash flow5/6 fields (83.3%)
    Per-share1/4 fields (25.0%)

    Financial statement coverage (AUD)

    Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.

    PeriodPeriod end RevenueNet incomeTotal assetsTotal equity Fields populatedSource
    FY2026 (AUD) 2026-06-30 29 yfinance
    FY2025 (AUD) 2025-06-30 29 yfinance
    FY2024 (AUD) 2024-06-30 30 yfinance
    FY2023 (AUD) 2023-06-30 23 yfinance

    Get RNV data via the API

    The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.

    Company profile

    Name, sector, industry, HQ, employees, market cap, source-tagged.

    GET /api/v1/companies/RNV

    Financial statements

    Multi-year statements with per-field source tags and completeness.

    GET /api/v1/companies/RNV/financials

    Computed ratios

    P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.

    GET /api/v1/companies/RNV/metrics/summary

    Filings archive

    Report PDFs with LLM-ready markdown conversions where available.

    GET /api/v1/companies/RNV/filings

    News & announcements

    Dated press releases and announcements with source links.

    GET /api/v1/companies/RNV/news

    Quick start

    Create a free key, then:

    curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/RNV

    Query RNV programmatically

    Free tier — instant API key. Built for AI agents.

    Other ASX · Health Care companies covered

    Frequently Asked Questions

    What data does the API provide for RNV?
    Stored coverage for RNV: price data available, financial statements available, 1 archived filings. REST endpoints are under /api/v1/companies/RNV; inspect available source metadata for provenance.
    How complete is RNV's financial data?
    The anchor reporting period (FY2026) has 82.4% of the 17 core statement fields populated. Primary source: yfinance.
    What reporting periods are covered for RNV?
    4 fiscal-year periods are stored (FY2023–FY2026), with per-period field counts and source tags available via /api/v1/companies/RNV/financials.
    Where does RNV's data come from?
    Stored price source: yfinance. Primary source for the statement snapshot: yfinance. Inspect available period and field source tags at /api/v1/companies/RNV/financials; missing tags do not establish provenance.